Latest News

Alzheimer's prevention trial to monitor reactions to higher disease risk status

A new clinical trial will soon begin testing whether early medical intervention in people at risk for Alzheimer's can slow down progression of disease pathology before symptoms emerge. As part of the overall prevention trial, neurodegenerative ethics experts will monitor how learning about their risk of developing Alzheimer's impacts trial participants.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • CEOs who motivate with 'fightin' words' shoot themselves in the foot

  • Knowledgeable consumers more likely to buy when given fewer options

  • Targeting the brain to treat obesity

  • Early warning sign for babies at risk of autism: Early joint attention predicts later autism symptoms

  • Creating sustainable STEM teacher programs

  • Klotho: neuroprotective against Alzheimer's disease

  • Cell therapy for multiple sclerosis patients: Closer than ever?

  • Computerized ADHD testing

  • Charter schools nationwide more cost-effective, produce greater ROI

  • 'Quack' child psychology practices identified by study

  •